Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc...

Published on 1 Nov 2024 on GuruFocus.com · via Yahoo Finance

Opportunities: Expansion into new markets and potential for pipeline development. Threats: Intense...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, w...

Insider Monkey · via Yahoo Finance 21 Nov 2024

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with t...

Zacks · via Yahoo Finance 21 Nov 2024

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we ...

Insider Monkey · via Yahoo Finance 20 Nov 2024

Opportunities: Expansion into new markets and potential for pipeline development. Threats: Intens...

GuruFocus.com · via Yahoo Finance 1 Nov 2024

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has reported a substantial increase in third-quarter...

Investing.com 31 Oct 2024

SAN RAFAEL, Calif. (AP) — BioMarin Pharmaceutical Inc. (BMRN) on Tuesday reported third-quarter e...

San Antonio Express-News 30 Oct 2024

We recently published a list of 10 Best Falling Stocks To Buy According to Hedge Funds. In this...

Insider Monkey · via Yahoo Finance 24 Oct 2024

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. ...

Insider Monkey · via Yahoo Finance 29 Aug 2024

We recently compiled a list of the Top 10 Stock Picks of Elliott Management. In this article, we ...

Insider Monkey · via Yahoo Finance 24 Jul 2024

Key Insights BioMarin Pharmaceutical's estimated fair value is US$142 based on 2 Stage Free Cash...

Simply Wall St. · via Yahoo Finance 23 Jun 2024